US FDA to Offer Final Approval for Pfizer Covid-19 Vaccine by September 2021


According to the reports, the US Food and Drug Administration (FDA) said, it is all set for offering the approval to the novel corona virus vaccine produced by Pfizer and BioNTech in the month of September 2021, and the US FDA has also set an unofficial deadline of Labor Day Holiday on 6th September 2021 for the purpose of giving the anti-corona virus vaccine shot green light.

The corona virus vaccine of Pfizer and BioNTech is currently being monitored through an emergency use authorization that had been granted in the month of December 2021, and the drug regulator said, by giving the authorization to the vaccine shot produced by Pfizer and BioNTech had been one of the key priorities of the US FDA.

According to the data, on 2nd August 2021, the United States of America had seen an average daily increase of 84,389 new corona virus cases over the last seven days, and around 192 million people of the United States had already got at least one dose of one of the novel corona virus vaccines that are available in the United States, which has been around 58 percent of the total population.

READ  Increasing Omicron Variant’s BA. 2 Subtype Worrying Scientists in UK

This final approval of the vaccine shot might be able to boost the confidence of the people of US, that are hesitant for the covid-19 vaccine for receiving the shot as the highly contagious Delta corona virus variant had been that had been increasing rapidly in the country, and this variant may be driving the daily number of the novel corona virus cases to the levels, which the country has not been seen since the month of February 2021.